The GAVI Full Country Evaluation project aims to understand and quantify the barriers to, as well as drivers of, immunization program improvement, including the contribution of the GAVI Alliance. The scope of the evaluation includes GAVI’s support for new and underused vaccines (including rotavirus, pneumococcal virus, and human papillomavirus), as well as GAVI’s cash-based support to recipient countries.
This four-year prospective evaluation, being conducted in India, Uganda, Zambia, Mozambique, and Bangladesh, began in 2012 and is led by the Institute for Health Metrics and Evaluation (IHME). HAI is the lead in-country partner for the Mozambique evaluation. Our role in this project includes leading the process evaluation, implementing and analyzing household and facility surveys, facilitating the resource tracking study, completing data analysis, and facilitating the training of Mozambique National Institute of Health and National Statistics Institute collaborators in advanced data analysis and modeling techniques.
These analyses will lead to essential data on the effectiveness and cost-effectiveness of immunization programs in Mozambique and will be used to directly inform policy and practice nationwide.
This evaluation is being supported by a grant from the IHME.
Click here to read the GAVI 2014 Progress report